Professor Megan Galbally
MBBS, MPM, FRANZCP, PhD
Foundation Chair in Perinatal Psychiatry
I hold a Bachelor of Medicine/Bachelor of Surgery and Masters of Psychological Medicine both from Monash University, a PhD from the University of Melbourne, and I am a Fellow of the Australian and New Zealand College of Psychiatrists. I have been an Office Bearer and Committee member for the Australasian Marce Society since 2003 including holding positions of President and Treasurer and I am currently an elected Board Member of the International Marce Society. I was a founding member and treasurer of the Perinatal and Infant Special Interest Group, RANZCP and established the Victorian Perinatal Special Interest Group in 2003. I currently also hold an honorary position in the Department of Obstetrics and Gynaecology at the University of Melbourne.
Previously I was Head of Unit, Perinatal Mental Health at Mercy Hospital for Women, in Melbourne, a service I developed and expanded over more than a decade to include a range of service initiatives including a specialised antenatal clinic for women with Schizophrenia and Bipolar Disorder.
My area of research focus is understanding the relationship between maternal mental illness and child developmental outcomes. I have led the development of two longitudinal research studies, Victorian Psychotropic Registry (VPR) and the Mercy Pregnancy and Emotional Wellbeing Study (MPEWS) in collaboration with researchers from a broad range of disciplines and institutions. The current study, MPEWS is a longitudinal, pregnancy cohort study co-led with Associate Professor Andrew Lewis. This study has been funded by a National Priority Research Grant from Beyond Blue and a 5 year NHMRC Project Grant. My research interests also include early parenting practices (breastfeeding, sleep, parent-child relationship) and mental health and models of antenatal care for women with Borderline Personality Disorder, Schizophrenia and Bipolar Disorder. An area of focus of both the VPR study and MPEWS is the effect of exposure to antidpressant medication in pregnancy on offspring outcomes. This research has resulted in national and international invitations to speak, invited publications including as lead editor of ‘Psychopharmacology and Pregnancy: Treatment Efficacy, Risks and Guidelines’ published by Springer, 2014 and as an expert advisor on the recent revised Clinical Practice Guidelines for Mood Disorders (RANZCP, 2015).
- Seth, S., Lewis, A., Galbally, M., (2016), Perinatal maternal depression and cortisol function in pregnancy and the postpartum period: A systematic literature review, BMC Pregnancy and Childbirth, 16, 1, .